Walgreens Boots Alliance (WBA) Projected to Post Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA) is projected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect Walgreens Boots Alliance to post earnings of $0.53 per share and revenue of $37.90 billion for the quarter. Walgreens Boots Alliance has set its FY 2025 guidance at 1.400-1.800 EPS and its FY25 guidance at $1.40-$1.80 EPS.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.66 EPS. On average, analysts expect Walgreens Boots Alliance to post $2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Walgreens Boots Alliance Trading Down 0.1 %

Walgreens Boots Alliance stock opened at $11.16 on Thursday. The business has a 50 day moving average price of $10.93 and a two-hundred day moving average price of $9.80. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The stock has a market cap of $9.64 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $22.05.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on WBA shares. Royal Bank of Canada increased their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. StockNews.com started coverage on Walgreens Boots Alliance in a report on Tuesday. They issued a “hold” rating for the company. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Finally, Evercore ISI increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.